- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Toshiba, Medcon forge alliance
Toshiba Medical Systems Europe has established a partnership with Medcon Ltd. The two firms hope the alliance will help each company develop and market advanced digital angiographic site maps and integrated connectivity products. With the partnership,
Toshiba Medical Systems Europe has established a partnership with Medcon Ltd. The two firms hope the alliance will help each company develop and market advanced digital angiographic site maps and integrated connectivity products. With the partnership, TMSE of Zoetermeer, the Netherlands, adds Medcons cardiac network and archive offerings to its Infinix monoplane and biplane angiographic product line. Medcons products include telecardiology with voice overlay, as well as the ability to publish cardiac images on both an intranet and the Internet.
TMSE and Medcon have already won contracts with hospitals in six European sites, including the Great Ormond Street Hospital for Children in London, the Victoria General Hospital in Blackpool, U.K., and the Catholic University Hospital in Rome. The two firms emphasized that their alliance doesnt interfere with the activities of Medcons established dealers.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
